Becton raises debt for CareFusion buy; Researchers find biomarkers for TB treatment success;

@FierceMedDev: Welch Allyn partners with LKC to distribute novel diabetic retinopathy device. Story | Follow @FierceMedDev

@EmilyWFierce: Covidien loses battle in patent war with J&J as top U.S. patent court throws out $176M award. More | Follow @EmilyWFierce

> Becton Dickinson ($BDX) will offer senior unsecured notes, with proceeds of the offering going toward the acquisition of CareFusion. Release

> NIH researchers find PET and CT scans as successful biomarkers to predict antibiotic success in TB patients. Release

> Ekso Bionics raised $22.8 million of its $30.3 million goal from 157 investors in a funding round. SEC filing

> U.K. researchers found that teens with hearing impairment detected during infancy had higher reading comprehension than teens whose impairment was not detected until later in life. Story

Biotech News

@FierceBiotech: Does the 'sharing economy' have a place in biotech? More | Follow @FierceBiotech

@JohnCFierce: $GSK news blew away the rest of the yr's top 10 reports in terms of readers. And it was all industry/investors. Story | Follow @JohnCFierce

@DamianFierce: Sorting through $PFE for $BMY tweets is like a survey course in the epidemiology of bio Twitter BS. Highly recommended. | Follow @DamianFierce

> Juno expands its CAR-T arsenal with latest immuno-oncology deal. News

> Does the 'sharing economy' have a place in biotech? Article

> U.K. biotech Evgen plots a $31M IPO to push its vegetable-derived pipeline. More

Pharma News

@FiercePharma: Sanofi Chairman says French tax burden a killer for attracting execs. Story | Follow @FiercePharma

@EricPFierce: ICYMI: Sanofi, Viehbacher accused of kickback scheme in whistleblower suit. Article | Follow @EricPFierce

@CarlyHFierce: Reckitt CEO, nearing spinoff, thinks he can outdo Big Pharma in consumer health. Story | Follow @CarlyHFierce

> GSK changes its tune, plans to hold on to aging drug portfolio. More

> More turmoil in top ranks of Sanofi's diabetes business. News

> Reckitt CEO, nearing spinoff, thinks he can outdo Big Pharma in consumer health. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.